Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-11-18 Sale |
2022-11-22 4:07 pm |
Theravance Biopharma Inc. | TBPH | Hindman Andrew A. SVP, CHIEF FINANCIAL OFFICER |
65,000 | $11.02 | $716,242 | 384,714 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-11-20 Tax Withholding |
2022-11-22 4:07 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | Hindman Andrew A. SVP, CHIEF FINANCIAL OFFICER |
25,057 | $10.85 | 384,714 (Direct) |
View |
| 2022-08-19 Tax Withholding |
2022-08-23 7:00 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | Hindman Andrew A. SVP, CHIEF FINANCIAL OFFICER |
25,676 | $9.34 | 473,507 (Direct) |
View |
| 2022-07-25 Option Award |
2022-07-27 6:56 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | Hindman Andrew A. SVP, CHIEF FINANCIAL OFFICER |
20,000 | $0 | 499,183 (Direct) |
View |
| 2022-05-20 Tax Withholding |
2022-05-24 7:17 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | Hindman Andrew A. SVP, CHIEF FINANCIAL OFFICER |
3,365 | $8.74 | 479,183 (Direct) |
View |
| 2022-02-18 Tax Withholding |
2022-02-23 6:29 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | Hindman Andrew A. SVP, CHIEF FINANCIAL OFFICER |
25,973 | $9.61 | 481,285 (Direct) |
View |
| 2021-12-02 Option Award |
2021-12-06 7:53 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | Hindman Andrew A. SVP, Chief Financial Officer |
340,000 | $0 | 507,258 (Direct) |
View |
| 2021-11-19 Tax Withholding |
2021-11-23 8:22 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | Hindman Andrew A. SVP, CHIEF FINANCIAL OFFICER |
1,350 | $8.36 | 167,258 (Direct) |
View |
| 2021-08-20 Tax Withholding |
2021-08-24 6:55 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | Hindman Andrew A. SVP, Chief Financial Officer |
17,464 | $14.05 | 167,380 (Direct) |
View |
| 2021-05-20 Tax Withholding |
2021-05-24 6:10 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | Hindman Andrew A. SVP, Chief Financial Officer |
942 | $17.8 | 184,844 (Direct) |
View |
| 2021-02-20 Tax Withholding |
2021-02-23 6:07 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | Hindman Andrew A. SVP, Chief Financial Officer |
3,984 | $18.79 | 184,704 (Direct) |
View |
| 2021-02-08 Option Award |
2021-02-10 5:43 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | Hindman Andrew A. SVP, Chief Financial Officer |
65,000 | $0 | 188,688 (Direct) |
View |
| 2020-08-20 Tax Withholding |
2020-08-24 6:24 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | Hindman Andrew A. SVP, Chief Financial Officer |
4,323 | $18.22 | 123,135 (Direct) |
View |
| 2020-07-27 Option Award |
2020-07-29 5:05 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | Hindman Andrew A. SVP, Chief Financial Officer |
20,000 | $0 | 127,458 (Direct) |
View |